Long COVID cost the Australian economy almost $10 billion in 2022 – new research
September 2, 2024We calculated lost productivity due to long COVID. The impacts were greatest among people aged 30 to 49.
Brain Health and Prevention | World Brain Day
August 5, 2024For decades, researchers and the community alike have awaited a 'silver-bullet' style drug to treat Alzheimer's disease, the major cause of dementia which accounts for over 50% of cases. Available medicines reduce symptom progression but do not alter progression of the disease. What the results of multiple trials and the cost of any treatments has highlighted is a more fundamental issue: even if we do find a therapeutic treatment, it won't proactively prevent future genrations from developing the disease.
Research suggests higher intake of fruit reduces development of depression
July 1, 2024Globally, depression is a major public health concern. According to the World Health Organisation it is the largest contributor to non-fatal burden of disease, with more than 80% of this burden represented across low- and middle-income countries.
Why eating disorder care must be geared to neurodivergent patients
July 1, 2024One-third of people with an eating disorder are neurodivergent, yet traditional eating disorder research and treatments haven’t factored this into the equation.
Teenagers with ADHD more likely to self-harm, research shows
July 1, 2024New research has highlighted the higher risk of self-harm and suicide among teenagers with ADHD and the need for better-tailored intervention strategies.
Ketamine in tablet form shown to reduce symptoms of severe depression
July 1, 2024Recent research by Institute members has highlighted significant gender differences in how cognitive resilience factors influence the risk of mild cognitive impairment (MCI).
New Research finds Gender Differences in Cognitive Resilience and Mild Cognitive Impairment
July 1, 2024Recent research by Institute members has highlighted significant gender differences in how cognitive resilience factors influence the risk of mild cognitive impairment (MCI).
UNSW community celebrated in King’s Birthday Honours
June 12, 2024From the history of Australian mammals to improving mental health care and cancer medicine, UNSW community members have been honoured across a range of disciplines.
Australia is getting a new digital mental health service. Will it help? Here’s what the evidence says
June 3, 2024It sounds good in theory, but it doesn’t always work in practice. Here’s what the evidence from the UK and elsewhere shows so far.
Long-term prescription opioid use after hospital declining: study
June 3, 2024UNSW Sydney medical researchers have shed light on post-hospital prescription opioid use.
New research unit launched in Western Sydney
June 3, 2024UNSW Sydney joins forces with Western Sydney Local Health District to announce new research unit focused on developing state-of-the-art healthcare models.
Emerging researcher appointed to James Packer Chair in Mood Disorders at UNSW
May 9, 2024Dr Aswin Ratheesh is a leading clinical researcher in mood and psychotic disorders who is passionate about prompt and early access to interventions for people with such conditions.
Fostering Compassionate Communities for Mental Health
April 30, 2024As nominations open for the Australian Mental Health Prize, experts are uniting to underscore the critical need to foster compassionate communities.
Long-COVID study reveals immunological improvement two years after infection
April 18, 2024Immune abnormalities have largely resolved at 24 months in a cohort of patients with long COVID, providing optimism that long COVID can resolve over time.
$5.7m for clinical trials
April 17, 2024Three UNSW Sydney projects have been awarded funding under the government’s Medical Research Future Fund’s clinical trials activity initiative.
Study eases concern at antipsychotics use in pregnancy
March 18, 2024The use of antipsychotics during pregnancy isn’t linked to childhood neurodevelopmental disorders or learning difficulties, UNSW Sydney-led study shows – giving assurance to those concerned about continuing their medications during pregnancy.
Patients leaving hospital sometimes need opioids. Doctors can reduce risks of long-term use and dependence
April 27, 2023New national standards aim to change doctors' prescribing habits when patients with pain are discharged.
The vital role emergency departments play in frontline mental health care
April 27, 2023Almost one in 10 young people aged 12 to 15 years old report ever having self-harmed and the leading cause of death in Australia for young people aged 15 to 24 years old is suicide.
Neuropsychology Tool Streamlines Cognitive Assessment, Diagnosis and Care
April 27, 2023Currently, Australians can face delays of approximately 3 years on average between initial symptom presentation and a formal diagnosis of dementia.
Understanding Risk of Dementia and Alcohol Consumption
April 27, 2023The review, published in Addiction, has shown that abstaining from alcohol completely can actually increase the risk of dementia.
Mindgardens Neuroscience Network acknowledges the Traditional Owners of Country throughout Australia and recognises their continuing connection to land, waters and community. We pay our respect to them and their cultures, and to Elders past, present and emerging.
We acknowledge the voices of people with lived experience, their carers, families and kinship groups. We recognise the expertise acquired through living with a mental health, drug and alcohol or neurological disorder and acknowledge those who care for people on their recovery journey. We place lived experience at the heart of all that we do.
Brings together the strengths of four founding organisations
